Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Otero Jose Manuel received 2,110 Lexeo Therapeutics, Inc. shares as an award (Form 4)

Traded Sep 14, 2026 · Filed Sep 28, 2026

On Sep 14, 2026, Otero Jose Manuel (Chief Operating Officer) received 2,110 Lexeo Therapeutics, Inc. shares as an award at US$2.64 for US$5,570, leaving 138,288 shares. Filed Sep 28, 2026 (Form 4).

Awarded
2,110 shares
Price
US$2.64
Value
US$5,570
Holding after
138,288 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common StockAward2,110US$2.64138,288Direct

Source

View original at SEC

Related